Skip to main content
Log in

Phyto-mediated synthesis of CuO nanoparticles using aqueous leaf extract of Artemisia deserti and their anticancer effects on A2780-CP cisplatin-resistant ovarian cancer cells

  • Original Article
  • Published:
Biomass Conversion and Biorefinery Aims and scope Submit manuscript

Abstract

Cancer is the second leading cause of death in the word. The failure of the most common therapeutic strategies including chemotherapy and its side effects on normal tissues plus the development of chemoresistance cases has justified the global attempt to find an alternative medicinal approach for cancer treatment. The purpose of this study was to analyze the effect of green-synthesized CuO nanoparticles (CuO NPs) using aqueous leaf extract of the plant Artemisia deserti on A2780-CP cisplatin-resistant ovarian cancer cells. GC–MS analysis of A. deserti extract showed the presence of three main reductive phytocomponents. The properties of synthesized CuO NPs have been characterized using different techniques such as UV–vis, FESEM, TEM, EDX, FTIR, XRD, and DLS. The cytotoxicity effect of CuO NPs has been evaluated by MTT assay. The induction of apoptosis and the cell cycle arrest has been analyzed by flow cytometry and qRT-PCR, respectively. The overall results obtained from MTT assay, Annexin/PI staining, qRT-PCR, cell cycle analysis, and measurement of generated cellular ROS in A2780-CP cells showed that the synthesized CuO NPs could induce apoptosis in A2780-CP cells in a significant level. The results also indicated that the biosynthesized CuO NPs cause negligible amount of cell cytotoxicity on normal healthy human foreskin fibroblasts cells (HFF). These two advantages can make the biogenic synthesized CuO NPs a good candidate for further studies on cancer treatment approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Yang J et al (2018) STAT3-mediated Twist1 upregulation contributes to epithelial-mesenehymal transition in cisplatin resistant ovarian cancer. Int J Clin Exp Med 7:6749–6757

    Google Scholar 

  2. Sorrentino A et al (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 111:478–486

    Article  Google Scholar 

  3. Pokhriyal R et al (2019) Chemotherapy resistance in advanced ovarian cancer patients. Biomark Cancer 11:1–19

    Article  Google Scholar 

  4. Shen D-W et al (2012) Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmal Rev 6:706–721

    Article  Google Scholar 

  5. de Luca A, Parker LJ (2019) A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1–1. PNAS 116:1–9

    Google Scholar 

  6. Siddik ZH (2006) Cisplatin resistance: molecular basis of a multifaceted impediment. [book auth.] B Teicher. Cancer Drug Discovery and Development: Cancer Drug Resistance. pp 286–307

    Google Scholar 

  7. Kartalu M, Essigmann JM (2001) Mechanisms of resistance to cisplatin. Mutat Res Fundam Molec Mech Mutagen. 478:23–43

    Article  Google Scholar 

  8. Zhang Y et al (2015) Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP. Biomed Pharmacother 69:285–290

    Article  Google Scholar 

  9. Damia GBM (2019) Platinum resistance in ovarian cancer: role of DNA repair. Cancers 11(119):1–15

    Google Scholar 

  10. Ishida SM, McCormick F, Smith-McCune K, Hanahan D (2010) Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 17:574–583

    Article  Google Scholar 

  11. Kishimoto S, Yasuda M, Fukushima S (2017) Changes in the expression of various transporters as influencing factors of resistance to cisplatin. Anticancer Res 37:5477–5484

    Google Scholar 

  12. Chen HHW, Kou MT (2010) Role of glutathione in the regulation of cisplatin resistance in cancer chemotherapy. Met. Based Drugs 2010:1–7

    Article  Google Scholar 

  13. Okuno SSH, Kuriyama-Matsumura K, Tamba M, Wang H, Sohda S, Hamada H, Yoshikawa H, Kondo T, Bannai S (2003) Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer 88:951–956

    Article  Google Scholar 

  14. Beale PJRP, Boxall F, Sharp SY, Kelland LR (2000) BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. Br J Cancer 82:436–440

    Article  Google Scholar 

  15. Mansouri AZQ, Ridgway LD, Tian L, Claret F-X (2003) Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. Oncol Res 13:399–404

    Article  Google Scholar 

  16. Dai C-HLJ, Chen P, Jiang H-G, Wu M, Chen Y-C (2015) RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells. J Biomed Sci 22:77

    Article  Google Scholar 

  17. Deans AJ, West SC (2011) DNA interstrand crosslink repair and cancer. Nat Rev Cancer 11:467–480

    Article  Google Scholar 

  18. Safarzadeh E, Sandoghchian SS, Baradarn B (2014) Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharmaceut Bull 4(Suppl 1):421–427

    Google Scholar 

  19. Wang Z et al (2016) Precision or personalized medicine for cancer chemotherapy: is there a role for herbal medicine. Molecules 21(889):1–13

    Google Scholar 

  20. Rivera JO, Loya AM, Ceballos R (2013) Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integr Med 2(6):2–6

    Google Scholar 

  21. Nikbakht A, Kafi M (2008) The history of traditional medicine and herbal plants in Iran. Acta Hortic 790:255–258

    Article  Google Scholar 

  22. Wachtel-Galor S, Benzie IFF (2011) Chapter 1 Herbal medicine an introduction to its history, usage, regulation, current trends, and research needs in Herbal Medicine. Biomolecular and Clinical Aspects, 2nd edn. CRC Press/Taylor & Francis, Boca Raton

    Google Scholar 

  23. Lou HTVC et al (2019) Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med 14(48):1–58

    Google Scholar 

  24. Kooti W, Servatyari K (2017) Effective medicinal plant in cancer treatment, Part 2: Review Study. J Evid Based Complement Altern Med 22(4):982–995

    Article  Google Scholar 

  25. Hajdu Z et al (2014) Antiproliferative activity of artemisia asiatica extract and its constituents on human tumor cell lines. Planta Med 80:1692–1697

    Article  Google Scholar 

  26. Konstat-Korzenny E et al (2018) Artemisinin and its synthetic derivatives as a possible therapy for cancer. Med Sci 6(19):1–10

    Google Scholar 

  27. Zhang L et al (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83(5):761–769

    Article  Google Scholar 

  28. Huber DL (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1(50):482–501

    Article  Google Scholar 

  29. Tekade RK et al (2017) Nanotechnology for the development of nanomedicine. nanotechnology-based approaches for targeting and delivery of drugs and genes. Elsevier Science, New York, pp 3–61

    Chapter  Google Scholar 

  30. Chandra H et al (2019) Phyto-mediated synthesis of zinc oxide nanoparticles of Berberis aristata: characterization, antioxidant activity and antibacterial activity with special reference to urinary tract pathogens. Mater Sci Eng, C 102:212–220

    Article  Google Scholar 

  31. Jadoun S et al (2021) Green synthesis of nanoparticles using plant extracts: a review. Environ Chem Lett 19(1):355–374

    Article  Google Scholar 

  32. Halevas EG, Pantazaki AA (2018) Copper nanoparticles as therapeutic anticancer agents. Nanomed Nanotechnol J 2018:1–21

    Google Scholar 

  33. Roopan SM et al (2019) CuO/C nanocomposite: synthesis and optimization using sucrose as carbon source and its antifungal activity. Mater Sci Eng, C 101:404–414

    Article  Google Scholar 

  34. Rajeshkumar S et al (2021) Environment friendly synthesis copper oxide nanoparticles and its antioxidant, antibacterial activities using Seaweed (Sargassum longifolium) extract. J Molec Struct 2021:130724

    Article  Google Scholar 

  35. Nagajyothi P et al (2017) Green synthesis: in-vitro anticancer activity of copper oxide nanoparticles against human cervical carcinoma cells. Arab J Chem 10(2):215–225

    Article  Google Scholar 

  36. Siddiqi KS, Husen A (2020) Current status of plant metabolite-based fabrication of copper/copper oxide nanoparticles and their applications: a review. Biomater Res 24:1–15

    Article  Google Scholar 

  37. Kumar H et al (2018) Metallic nanoparticle: a review. Biomed J Sci Tech Res 4(2):1–11

    Google Scholar 

  38. Zhu X, Pathakoti K, Hwang HM (2019) Green synthesis of titanium dioxide and zinc oxide nanoparticles and their usage for antimicrobial applications and environmental remediation. In: Shukla Siavash AKI (ed) Green Synthesis, Characterization and Applications of Nanoparticles. Elsevier, Cambridge, pp 223–263

    Chapter  Google Scholar 

  39. Hwang HM, Ray P, Yu H, He X (2012) Toxicology of designer/engineered metallic nanoparticles. Sustainable preparation of metal nanoparticles: methods and applications. RSC green chemistry book series. The Royal Society of Chemistry, London, pp 190–212

    Chapter  Google Scholar 

  40. Puzyn T, Rasulev B, Gajewicz A, Hu X-K, Dasari TP, Michalkova A, Hwang H-M, Toropov A, Leszczynska D, Leszczynski J (2011) Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 6:175–178

    Article  Google Scholar 

  41. Singh S et al (2017) Electrochemical sensing and remediation of 4-nitrophenol using bio-synthesized copper oxide nanoparticles. Chem Eng J 313:283–292

    Article  Google Scholar 

  42. Letchumanan D et al (2021) Plant-based biosynthesis of copper/copper oxide nanoparticles: an update on their applications in biomedicine, mechanisms, and toxicity. Biomolecules 11(4):564

    Article  Google Scholar 

  43. Qian Y, Yao J, Russel M, Chen K, Wang X (2015) Characterization of green synthesized nanoformulation (ZnO–A. vera) and their antibacterial activity against pathogens. Environ Toxicol Pharmacol 39:736–746

    Article  Google Scholar 

  44. Bezabeh T, Mowat MRA (2001) Detection of drug-induced apoptosis and necrosis in human cervical carcinoma cells using 1H NMR spectroscopy. Cell Death Differ 8:219–224

    Article  Google Scholar 

  45. Mousavi B, Tafvizi F, Bostanabad SZ (2018) Green synthesis of silver nanoparticles using Artemisia turcomanica leaf extract and the study of anti-cancer effect and apoptosis induction on gastric cancer cell line AGS. Artif Cells Nanomed Biotechnol 46(sup1):499–510

    Article  Google Scholar 

  46. Rabiee N et al (2020) Biosynthesis of copper oxide nanoparticles with potential biomedical applications. Int J Nanomed 15:3983

    Article  Google Scholar 

  47. Rahimivand M, Tafvizi F, Noorbazargan H (2020) Synthesis and characterization of alginate nanocarrier encapsulating Artemisia ciniformis extract and evaluation of the cytotoxicity and apoptosis induction in AGS cell line. Int J Biol Macromol 158:338–357

    Article  Google Scholar 

  48. Mohammadi SA, Tafvizi F, Noorbazargan H (2021) Anti-cancer effects of biosynthesized zinc oxide nanoparticles using Artemisia scoparia in Huh-7 liver cancer cells. Inorg Nano-Metal Chem 2021:1–12

    Google Scholar 

  49. Fard SE, Tafvizi F, Torbati MB (2018) Silver nanoparticles biosynthesised using Centella asiatica leaf extract: apoptosis induction in MCF-7 breast cancer cell line. IET Nanobiotechnol 12(7):994–1002

    Article  Google Scholar 

  50. Ketab RSG, Tafvizi F, Khodarahmi P (2021) Biosynthesis and chemical characterization of silver nanoparticles using Satureja rechingeri Jamzad and their apoptotic effects on AGS gastric cancer cells. J Clust Sci 32(5):1389–1399

    Article  Google Scholar 

  51. Aslany S, Tafvizi F, Naseh V (2020) Characterization and evaluation of cytotoxic and apoptotic effects of green synthesis of silver nanoparticles using Artemisia Ciniformis on human gastric adenocarcinoma. Mater Today Commu 24:101011

    Article  Google Scholar 

  52. Roesslein M et al (2013) Comparability of in vitro tests for bioactive nanoparticles: a common assay to detect reactive oxygen species as an example. Int J Molec Sci 14:24320–24337

    Article  Google Scholar 

  53. Shulaev V, Oliver DJ (2006) Metabolic and proteomic markers for oxidative stress. New tools for reactive oxygen species research. Plant Physiol 141:367–372

    Article  Google Scholar 

  54. Konappa N et al (2020) Gc–MS analysis of phytoconstituents from Amomum nilgiricum and molecular docking interactions of bioactive serverogenin acetate with target proteins. Sci Rep 10(1638):1–23

    Google Scholar 

  55. Grassman J (2005) Terpenoids as Plant Antioxidants. Vitam Horm 72:505–535

    Article  Google Scholar 

  56. Abu-Izneid T, Rauf A, Shariati MA (2020) Sesquiterpenes and their derivatives-natural anticancer compounds: an update. Pharmacol Res 161(105165):1–20

    Google Scholar 

  57. Samphath S et al (2017) Evaluation of in vitro anticancer activity of 1,8-Cineole–containing n-hexane extract of Callistemon citrinus (Curtis) Skeels plant and its apoptotic potential. Biomed Pharmacother 93:296–307

    Article  Google Scholar 

  58. Rajeswer Rao V (2016) Antioxidant agents. Advances in structure and activity relationship of Coumarin Derivatives. Academic Press, Cambridge, pp 137–150

    Google Scholar 

  59. Ebrahiminezhad A et al (2018) Plant-mediated synthesis and applications of iron nanoparticles. Mol Biotechnol 60:154–168

    Article  Google Scholar 

  60. Mendhulkar VD, Yadav A (2017) Anticancer activity of camellia sinensis mediated copper nanoparticles against HT-29, MCF-7, AND MOLT-4 human cancer cell lines. Asian J Pharm Clin Res 10(2):71–77

    Article  Google Scholar 

  61. Mukhopadhyay R, Kazi J, Debnath MC (2018) Synthesis and characterization of copper nanoparticles stabilized with Quisqualis indica extract: evaluation of its cytotoxicity and apoptosis in B16F10 melanoma cells. Biomed Pharmacother 97:1373–1385

    Article  Google Scholar 

  62. Chandra H et al (2020) Promising roles of alternative medicine and plant-based nanotechnology as remedies for urinary tract infections. Molecules 25(23):5593

    Article  Google Scholar 

  63. Chandra H et al (2020) Medicinal plants: treasure trove for green synthesis of metallic nanoparticles and their biomedical applications. Biocatal Agricult Biotechnol 24:101518

    Article  Google Scholar 

  64. Tshireletso P, Ateba CN, Fayemi OE (2021) Spectroscopic and antibacterial properties of CuONPs from orange, lemon and tangerine peel extracts: potential for combating bacterial resistance. Molecules 26:586

    Article  Google Scholar 

  65. Kanninen P et al (2008) Influence of ligand structure on the stability and oxidation of copper nanoparticles. J Colloid Interface Sci 318:88

    Article  Google Scholar 

  66. Honary S et al (2012) Green synthesis of copper oxide nanoparticles using Penicillium aurantiogriseum, Penicillium citrinum and Penicillium waksmanii. Dig J Nanomater Bios 2012:999–1005

    Google Scholar 

  67. Sankar R et al (2014) Green synthesis of colloidal copper oxide nanoparticles using Carica papaya and its application in photocatalytic dye degradation. Spectrochim Acta Part A Mol Biomol Spectrosc 121:746–750

    Article  Google Scholar 

  68. Alswat AA et al (2017) Copper oxide nanoparticles-loaded zeolite and its characteristics and antibacterial activities. J Mater Sci Technol 33:889–896

    Article  Google Scholar 

  69. Menazea A (2020) One-Pot Pulsed Laser Ablation route assisted copper oxide nanoparticles doped in PEO/PVP blend for the electrical conductivity enhancement. J Mater Res Technol 2020:127807. https://doi.org/10.1016/j.jmrt.2019.12.073

    Article  Google Scholar 

  70. Mali SC, Raj S, Trivedi R (2019) Biosynthesis of copper oxide nanoparticles using Enicostemma axillare (Lam) leaf extract. Biochem Biophys Rep 20:100699

    Google Scholar 

  71. Sathiyavimal S et al (2018) Biogenesis of copper oxide nanoparticles (CuONPs) using Sida acuta and their incorporation over cotton fabrics to prevent the pathogenicity of Gram negative and Gram positive bacteria. J Photochem Photobiol B 188:126–134

    Article  Google Scholar 

  72. Velsankar K et al (2020) Green synthesis of CuO nanoparticles via Allium sativum extract and its characterizations on antimicrobial, antioxidant, antilarvicidal activities. J Environ Chem Eng 8(5):104123

    Article  Google Scholar 

  73. Aslanturk OS (2018) In vitro cytotoxicity and cell viability assays: principles, advantages, and disadvantages. In: Larramendy ML (ed) Genotoxicity - A Predictable Risk to Our Actual World. Intech Open, London, pp 1–17

    Google Scholar 

  74. Reutelingsperger CPM, van Heerdee WL (1997) Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Molec Life Sci 53:527–532

    Article  Google Scholar 

  75. Roy S, Nicholson DW (2000) Cross-talk in cell death signaling. J Exp Med 192(8):F21–F26

    Article  Google Scholar 

  76. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516

    Article  Google Scholar 

  77. Crowley LC et al (2016) Quantitation of apoptosis and necrosis by annexin V binding propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc 2016:87288

    Google Scholar 

  78. Alshatwi AA et al (2016) Synergistic anticancer activity of dietary tea polyphenols and bleomycin hydrochloride in human cervical cancer cell: caspase-dependent and independent apoptotic pathways. Chem Biol Interact 247:1–10

    Article  Google Scholar 

  79. Amable L (2016) Cisplatin resistance and opportunities for precision medicine. Pharmacol Res 106:27–36

    Article  Google Scholar 

  80. Ahmad S (2017) Kinetic aspects of platinum anticancer agents. Polyhedron 138:109–124

    Article  Google Scholar 

  81. Astolfi L et al (2013) Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation. Oncol Rep 29(4):1285–1292

    Article  Google Scholar 

  82. Johnstone TC, Suntharalingam K, Lippard SJ (2016) The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chem Rev 116(5):3436–3486

    Article  Google Scholar 

  83. Xiong X et al (2014) Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. Oncotarget 5(15):6453

    Article  Google Scholar 

  84. Ramezani T et al (2019) Sensitization of resistance ovarian cancer cells to cisplatin by biogenic synthesized silver nanoparticles through p53 activation. Iran J Pharmaceut Res 18(1):222

    MathSciNet  Google Scholar 

  85. Zhou X et al (2014) Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma. Neoplasia 16(12):1028–1035

    Article  Google Scholar 

  86. Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochem Biophys Acta 1863:2977–2992

    Article  Google Scholar 

  87. Higuchi M et al (1998) Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17:2753–2760

    Article  Google Scholar 

  88. Komoriya A et al (2000) Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J Exp Med 191(11):1819–1828

    Article  Google Scholar 

  89. Dai Y, Jin S, Li X, Wang D (2017) The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer. Oncotarget 8(1):1354–1368

    Article  Google Scholar 

  90. Cooper GM, Hausman RE (2007) The cell: a molecular approah, 4th edn. Sinauer Associates Inc., Sunderland

    Google Scholar 

  91. Pozarowski P, Darzynkiewicz Z (2004) Analysis of cell cycle by flow cytometry. Methods in Molecular Biology, vol. 281: Checkpoint Controls and Cancer, Volume 2: Activation and Regulation Protocols. Humana Press, Los Angeles, pp 301–311

    Google Scholar 

  92. Azizi M, Ghourchian H (2017) Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231. PLoS ONE 12(11):1–21

    Article  Google Scholar 

  93. Sarayana R, Mubarak MA (2017) Synthesis of Colloidal copper nanoparticles and its cytotoxicity effect on MCF-7 breast cancer cell lines. J Chem Pharmaceut Sci 974:2115

    Google Scholar 

  94. Hassanien R, Husein DZ, Al-Hakkani MF (2018) Biosynthesis of copper nanoparticles using aqueous Tilia extract: antimicrobial and anticancer activities. Heliyon 4:e01077

    Article  Google Scholar 

  95. Reddy Prasad P, Kanchi S, Naidoo EB (2016) In-vitro evaluation of copper nanoparticles cytotoxicity on prostate cancer cell lines and their antioxidant, sensing and catalytic activity: one-pot green approach. J Photochem Photobiol B: Biol 375:382. https://doi.org/10.1016/j.jphotobiol.2016.06.008

    Article  Google Scholar 

  96. Gnanavel V, Palanichamy V, Roopan SM (2017) Biosynthesis and characterization of copper oxide nanoparticles and its anticancer activity on human colon cancer cell lines (HCT-116). J Photochem Photobiol B: Biol 17:133–138

    Article  Google Scholar 

  97. Roopan SM, Sharma H, Kumar G, Mishra A, Agarwal V, Agrawaal H, Elango G, Damodharan KI, Elumalai K (2019) A green systematic approach of carbon/CuO nano composites using Aristolochia bracteolate by response surface methodology. J Clust Sci 30:1177–1183

    Article  Google Scholar 

  98. Priya DD, Elango G, Roopan SM, Shanavas S, Acevedo R, Golkonda M, Sridharan M (2020) Abutilon indicum mediated CuO nanoparticles: ecoapproach, optimum process of Congo red dye degradation, and mathematical model for multistage operation. Chem Sel 5:8572–8576

    Google Scholar 

  99. Chakraborty R, Basu T (2017) Metallic copper nanoparticle induces apoptosis in human skin melanoma, A-375 cell line. IOP Sci 28:2–33

    Google Scholar 

  100. Kumari P, Panda PK, Jha E, Kumari Kh, Nisha K, Anwar Mallick M, Verma SK (2017) Mechanistic insight to ROS and Apoptosis regulated cytotoxicity inferred by green synthesized CuO nanoparticles from Calotropis gigantea to Embryonic zebrafish. Sci Rep 7(16284):1–17

    Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the laboratory of the Islamic Azad University.

Author information

Authors and Affiliations

Authors

Contributions

S.Sh performed most of the experiments, methodology, writing, and cell culture study. F.T contributed to this study by designing the experimental plans, performing data analysis, supervision, writing (review and editing), and project administration. M.Sh and P.Kh contributed to designing the experimental plan and data analysis in synthesis of nanoparticles and characterization.

Corresponding author

Correspondence to Farzaneh Tafvizi.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahriary, S., Tafvizi, F., Khodarahmi, P. et al. Phyto-mediated synthesis of CuO nanoparticles using aqueous leaf extract of Artemisia deserti and their anticancer effects on A2780-CP cisplatin-resistant ovarian cancer cells. Biomass Conv. Bioref. 14, 2263–2279 (2024). https://doi.org/10.1007/s13399-022-02436-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13399-022-02436-x

Keywords

Navigation